세계의 공캡슐 시장 : 유형별, 원재료별, 기능성별, 용도별, 사이즈별, 최종사용자별 - 예측(-2030년)
Empty Capsules Market by Type, Raw Material, Functionality, Application, Size, End User - Global Forecast to 2030
상품코드:1800732
리서치사:MarketsandMarkets
발행일:2025년 08월
페이지 정보:영문 460 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 공캡슐 시장 규모는 2025년 추정 31억 9,000만 달러에서 2030년까지 41억 9,000만 달러에 달할 것으로 예측되며, 2025-2030년 동안 5.6%의 CAGR로 성장할 것으로 전망됩니다.
조사 범위
조사 대상 연도
2024-2030년
기준 연도
2024년
예측 기간
2025-2030년
단위
10억 달러
부문
유형, 원재료, 기능성, 사이즈, 치료 용도, 최종사용자, 지역
대상 지역
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카
이 시장은 건강기능식품 및 맞춤형 보충제에 대한 수요 증가, 의약품 연구개발의 성장, 기능성 캡슐 및 방출 제어 캡슐의 기술 혁신에 의해 활성화되고 있습니다. 채식주의자 및 클린 라벨 지향으로의 현저한 변화, 지속가능성을 중시하는 규제는 그 확산을 더욱 촉진하고 있습니다. 향후 성장은 신흥 시장에서의 현지 생산과 생분해성 캡슐의 창출을 통해 이루어질 가능성이 높습니다.
"돼지 유래 캡슐은 젤라틴 캡슐 시장에서 가장 큰 원료 부문으로 가장 높은 CAGR로 성장할 것으로 예상됩니다."
돼지 젤라틴 캡슐 시장은 가장 큰 원료 카테고리이며, 비용 효율성과 광범위한 가용성으로 인해 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다. 돼지 젤라틴은 우수한 겔화 특성으로 인해 고체형 및 방출 제어형을 포함한 다양한 약물에 적합하기 때문에 제약 산업 및 건강보조식품 산업에서 널리 사용되고 있습니다.
"제약 산업 부문이 2024년 최종사용자 부문에서 가장 높은 점유율을 차지했습니다."
제약 산업은 공캡슐의 가장 큰 최종사용자이며, 처방약, OTC 의약품, 치료약의 전달에 널리 사용됩니다. 이 캡슐은 일반적으로 항생제, 진통제, 항고혈압제, 만성질환을 관리하는 다른 약물과 같은 고체 약물의 경구 투여에 사용됩니다. 캡슐은 삼키기 쉽고, 정확한 투여가 가능하며, 다양한 약물을 캡슐화할 수 있어 제약 부문에서 선호하는 제형입니다.
북미는 2025-2030년 세계 공캡슐 시장에서 가장 큰 시장이 될 것입니다.
2024년 북미, 특히 미국과 캐나다가 선진화된 제조 인프라와 탄탄한 규제 프레임워크에 힘입어 의약품 및 건강보조식품에 대한 수요가 강해지면서 공캡슐의 최대 시장이 될 것으로 예상됩니다. 기술 혁신에 대한 지속적인 투자를 통해 즉시 방출 및 방출 제어 약물전달과 같은 다양한 용도의 고품질 캡슐이 개발되고 있습니다. 예방 의료와 웰빙에 대한 소비자의 관심에 힘입어 건강기능식품에 대한 수요가 증가하면서 시장 성장을 더욱 촉진하고 있습니다. 또한, 이 지역은 방출 제어 캡슐 및 장용성 코팅 캡슐을 포함한 새로운 약물전달 형태의 채택을 촉진하는 양호한 규제 환경의 혜택을 누리고 있습니다. 또한, 아시아태평양은 의약품 생산능력의 확대, 낮은 생산 비용, 정부 지원 정책으로 인해 이 기간 동안 가장 빠른 성장을 보일 것으로 예상됩니다. 중국, 인도, 한국과 같은 국가들은 숙련된 노동자 인구, 저렴한 비용, 유리한 정책으로 인해 중요한 제조 거점이 되고 있습니다.
세계의 공캡슐 시장에 대해 조사 분석했으며, 주요 촉진요인과 저해요인, 경쟁 상황, 향후 동향 등의 정보를 전해드립니다.
SHANDONG HEALSEE CAPSULE LTD.(SHANDONG HEAD GROUP CO., LTD.)
CAPSCANADA
FARMACAPSULAS
SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.
ERAWAT PHARMA LIMITED
기타 기업
SAVIOURCAPS
SHANXI JC BIOLOGICAL TECHNOLOGY CO.
ROXLOR
MEDISCA INC.
ZHEJIANG YUEXI CAPSULE CO., LTD.
SHAOXING KANGKE CAPSULE CO., LTD.
ZHEJIANG HUILI CAPSULES CO., LTD.
SHAOXING ZHONGYA CAPSULE CO., LTD.
SHING LIH FANG ENTERPRISE CO., LTD.
LEFANCAPS
CHEMCAPS LIMITED
BIOCAPS ENTERPRISE
SNAIL PHARMA INDUSTRY
BRIGHT PHARMA CAPS
SHREE PHARMA CAPS
HEXIN CAPSULE CO., LTD.
WUHAN CARMA TECHNOLOGY CO., LTD.
AIPAK PHARMA
제15장 부록
KSM
영문 목차
영문목차
The global empty capsules market is projected to reach USD 4.19 billion by 2030 from an estimated USD 3.19 billion in 2025, at a CAGR of 5.6% from 2025 to 2030.
Scope of the Report
Years Considered for the Study
2024-2030
Base Year
2024
Forecast Period
2025-2030
Units Considered
Value (USD billion)
Segments
Type, Raw Material, Functionality, Size, Therapeutic Application, End User, and Region
Regions covered
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
The market is fueled by increasing demand for nutraceuticals and personalized supplements, growth in pharmaceutical R&D, and innovations in functional and modified-release capsules. A significant shift toward vegetarian and clean-label options and sustainability-focused regulations is further driving adoption. Future growth is likely to come from localized production in emerging markets and the creation of biodegradable capsules.
"The porcine-derived capsules will continue to be the largest raw material segment in the gelatin capsules market, growing at the highest CAGR."
The gelatin empty capsules market is segmented based on raw material into porcine gelatin, bovine-derived gelatin, bone meal, and other gelatin sources. The non-gelatin capsules market is further categorized into hydroxypropyl methylcellulose (HPMC) and pullulan & starch. The porcine gelatin capsule market is the largest raw material category and is expected to experience the highest growth rate during the forecast period, due to its cost-effectiveness and wide availability. Porcine gelatin is widely used in the pharmaceutical and nutraceutical industries because of its excellent gelling properties, making it suitable for various drug formulations, including solid and controlled-release types.
"Pharmaceutical industry segment reported the highest share of the end user segment in 2024."
Based on end users, the empty capsules market is categorized into pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories. The pharmaceutical industry is the largest end user of empty capsules, widely using them for delivering prescription drugs, over-the-counter (OTC) medications, and therapeutic treatments. These capsules are commonly used for oral administration of solid drugs like antibiotics, pain relievers, antihypertensives, and other medications for managing chronic diseases. Capsules are a preferred dosage form in the pharmaceutical sector because they are easy to swallow, provide accurate dosing, and can encapsulate a broad range of drugs.
North America accounted for the largest global empty capsules market from 2025 to 2030.
In 2024, North America, especially the US and Canada, will be the largest market for empty capsules due to strong demand in pharmaceuticals and nutraceuticals, supported by advanced manufacturing infrastructure and robust regulatory frameworks. Ongoing investments in technology and innovation have led to the development of high-quality capsules for various applications, such as immediate and controlled-release drug delivery. The rising demand for dietary supplements, driven by consumer interest in preventive healthcare and wellness, further fuels market growth. The region also benefits from a favorable regulatory environment, which encourages the adoption of new drug delivery formats, including controlled-release and enteric-coated capsules. Additionally, the Asia Pacific region is expected to see the fastest growth during this period, thanks to expanding pharmaceutical manufacturing capabilities, lower production costs, and supportive government policies. Countries like China, India, and South Korea are becoming key manufacturing hubs due to their large skilled labor pools, low costs, and favorable policies.
The primary interviews conducted for this report can be categorized as follows:
By Respondent: Supply Side-70% and Demand Side-30%
By Designation: Managers-45%, CXO and Directors-30%, and Executives-25%
By Region: North America-40%, Europe-25%, the Asia Pacific-20%, Latin America-10%, and the Middle East & Africa-5%
This research report categorizes the empty capsules market, by type (gelatin capsules, non-gelatin capsules), by raw materials (gelatin [porcine-derived gelatin, bovine-derived gelatin, bone meal-derived gelatin, other gelatin sources], non-gelatin [hpmc, pullulan & starch]), functionality (immediate-release, sustained-release, delayed-release), size (Size 000, Size 00, Size 0, Size 1, Size 2, Size 3, Size 4, Size 5), therapeutic application (antibiotic & antibacterial drugs, dietary supplements, antacid & ant flatulent preparations, anti-anaemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, other therapeutic applications), end user (pharmaceutical industry, nutraceutical industry, cosmetic industry, research laboratories) and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).
The scope of the report covers detailed information about major factors such as drivers, restraints, challenges, and opportunities that influence the growth of the empty capsules market. A thorough analysis of key industry players has been conducted to provide insights into their business overview, products, and key strategies, including new product launches, collaborations, and partnership agreements.
Key Benefits of Buying the Report:
The report will assist market leaders and new entrants by providing close estimates of revenue in the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to more effectively position their businesses and develop appropriate go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on the key drivers, restraints, opportunities, and challenges within the market.
The report provides insights on the following pointers:
Analysis of key drivers (growth in nutraceuticals & personalized supplements market, growing focus on pharmaceutical development and subsequent increase in clinical trials, expansion of functional & modified-release capsules, sustainability & regulatory-driven transition, increasing preference for self-medication and OTC drugs, shift toward vegetarian & clean-label capsules) restraints (dietary restrictions associated with gelatin consumption, issues related to safety and efficacy, competition from other drug delivery technologies), opportunities (geographic expansion & localized production in emerging economies, development of biodegradable and sustainable capsules), and challenges (challenges associated with logistics and storage of empty capsules, raw material availability & supply chain dependence)
Product Development/Innovation: Detailed insights on upcoming products, technologies, research & development activities in the empty capsules market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the empty capsules market
Competitive Assessment: In-depth assessment of market shares, company revenue, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/approvals, acquisitions, partnerships, agreements, collaborations, expansions, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the empty capsules market.
